אילן זעפרן

2018-2021        PhD. Student- Immuno-Pharmacology/ Pharmacy

The Hebrew University of Jerusalem

Topic: Exploiting candida albicans interactions with Mast cells and Eosinophils for the treatment of colon cancer

Supervisor: Prof. Francesca Levi Schaffer

2016-2018        MSc. Immuno-/Pharmacology Final grade: 90.4

The Hebrew University of Jerusalem

Topic: Activation of the Ceacam1 inhibitory receptor: A novel approach to treat melanoma Supervisor: Prof. Francesca Levi Schaffer

2010-2015        BSc. Pharmaceutical engineering- Final grade: 80.3

Azrieli College of Engineering Jerusalem

2002-2005        High School diploma

ישיבה תיכונית בית יהודה- כפר מימון

2018-                Oncology Pharmacy course

Continuing Pharmacy Education, School of Pharmacy, The Hebrew University of Jerusalem

2020-2021          Hadassa Hospital-Virology unit

Jerusalem         Corona laboratory test.

2020-2021          Azrieli college of engineering- Teacher Assistant

Jerusalem         Teacher assistant in heat transfer and Process Engineering laboratory.

2018-2021          The Hebrew University of Jerusalem- Teacher Assistant

Jerusalem          Teacher assistant in pharmacology for pharmacist and medical student.

2015-2016           Biolab- Biotechnician

Jerusalem          Accurately prepared lab chemicals, biological and supplies.

2014-2015           Biokine- Assistant Researcher

Jerusalem          R&D project on cancer therapy. Identify, purify, and devellop a small molecule       from plant extract and test its effect on different cancer.

• Activation of CEACAM1 with an agonistic mAb results in inhibition of melanoma cells. Zaffran Ilan, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Jonjic Stipan, Ofer Mandelboim, Bernhard B. Singer & Francesca Levi-Schaffer. Cancer gene therapy. https://doi.org/10.1038/s41417-022-00486-x

• The regulatory role of eosinophils in viral, bacterial, and fungal infections.

Pratibha Gaur, Ilan Zaffran, Tresa George, Fidan Rahimli Alekberli, Micha Ben-Zimra, Francesca Levi-Schaffer, Clinical and Experimental Immunology, 2022;uxac038, https://doi.org/10.1093/cei/uxac038.

• Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.

Landolina N, Zaffran I, Smiljkovic D, Serrano-Candelas E, Schmiedel D, Friedman S, Arock M, Hartmann K, Pikarsky E, Mandelboim O, Martin M, Valent P, Levi-Schaffer F. Pharmacol Res. 2020 Feb 5:104682. doi: 10.1016/j.phrs.2020.104682.

• Siglec-7 on peripheral blood eosinophils: Surface expression and function.

Legrand F, Landolina N, Zaffran I, Emeh RO, Chen E, Klion AD, Levi-Schaffer F.

Allergy. 2019 Jul;74(7):1257-1265. doi: 10.1111/all.13730.

• Fay and Bert Harbour Award.
• Jacob I. Schaffer Memorial Research Scholarship for MSc. Students.
• The Israeli Scholarship Education Foundation (ISEF) for PhD excellence in academic and social leadership

• The American Association of Immunologist (AAI) Annual Meeting-IMMUNOLOGY2022: “COVID-19 patients have increased levels of membrane-associated and soluble CD48”.
• • Collegium Internationale Allergoligicum (CIA)- 2022 Virtual Academy Session Series: “COVID-19 patients display dysregulated expression of CD48 activating and CD300a inhibitory receptors: a hint to its etiopathogenesis?”.
  • British Pharmacologial Society (BPS) congress- Pharmacology 2021: “Development of CEACAM1 monoclonal antibody for the treatment of melanoma” – iPoster presentation.
  • The Annual ISEF conference 2021: “Activation of the Siglec-7 inhibitory receptor: A novel approach for fighting cancer” – Poster presentation.
  • IIS-ISCR Special Conference - The Cutting Edge of Immunology, Cancer, and Immunoncology Research 2019 Tel Aviv: “Activation of the Siglec-7 inhibitory receptor: A novel approach for fighting cancer”- Oral presentation.
  • ISPP 2019 Annual meeting, Jerusalem: “Siglec-7 on peripheral blood eosinophils: Surface expression and function”- Poster presentation.

   

  Languages:      English: Good

                               French: Fluent

                               Hebrew: Fluent